What this means
This plan aims to follow 2,800 people aged 55 and older over many years. It has not started enrolling, so no results exist yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 55–90 · 2,800 adults aged 55 and older planned
- Where
- 2 sites
The science
- Registered title
- Westlake Aging Cohort (WeAC)
- Trial ID
- NCT07373444 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Aging, Cognition Improvement, Cognition Disorders, Cognition
- Sponsor
- Westlake University
- Ages
- 55 Years to 90 Years
- Dates
- First posted Jan 28, 2026 · updated Jan 28, 2026
Registry summary
The Westlake Ageing Cohort (WeAC) is a longitudinal cohort study conducted in Hangzhou, Zhejiang Province, China. The investigators aim to enroll 2,800 participants aged 55 years and older for long-term follow-up. The population will include individuals with neurodegenerative diseases or those at the prodromal stage of cognitive impairment, as well as healthy middle-aged and older adults serving as controls. The investigators will collect their sociodemographic, dietary, lifestyle, clinical, and neuroimaging data, as well as biological samples.
Sites (2)
- Hangzhou First People's Hospital, Hangzhou, Zhejiang, China
- Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China